LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
NCT00006007
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
gemcitabine hydrochloride
DRUG:
pemetrexed disodium
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
[object Object]